Certificate of Analysis

* For quality assurance purposes. Not a Maine compliance certificate.

White Runtz (Flower)

Produced: Sep 29, 2021

Client: Cannabis Culture // Batch Result: Pass

Img

Matrix: Flower

Category: Inhalable

Sample ID: NAL-210927-025

Collected on: Sep 27, 2021

Received on: Sep 27, 2021

Sample Size: 3.2 g

Sampled By: Andrew Patterson

Received By: Andrew Patterson

THCA

27.1 %

27.1 %

CBGA

1.03 %

1.03 %

Total Cannabinoids

29.2 %

29.2 %

Cultivator

Charles N. Crapps

License

CGR26612

Type

Medicinal - Caregiver

Results Certified By: Barry Chaffin

COO, Nova Analytic Labs

Sep 29, 2021

Signature

Results Certified By: Greg Newland

CSO, Nova Analytic Labs

Sep 29, 2021

Signature

Results Certified By: Chris Altomare

CEO, Nova Analytic Labs

Sep 29, 2021

Signature

Nova Analytic Labs // 65 Milliken Street, Unit C Portland ME 04103 // PH: 2074664661

Email: innovation@nova-analyticlabs.com

ME License #: TF284

CAN.1: Potency & Cannabinoid Profile by HPLC-UV

Preparation: Sep 28, 2021

Analysis: Sep 29, 2021

Reported on an as received basis
1000 µg/g = 1 mg/g

Analyte Detected Pass/Fail
CBC ND N/A
CBCA ND N/A
CBD ND N/A
CBDA ND N/A
CBDV ND N/A
CBDVA ND N/A
CBG 0.230 % N/A
CBGA 1.03 % N/A
CBL ND N/A
CBLA ND N/A
CBN ND N/A
CBNA ND N/A
Δ8-THC ND N/A
Δ9-THC 0.536 % N/A
Δ10-THC ND N/A
Exo-THC ND N/A
THCA 27.1 % N/A
THCV ND N/A
THCVA 0.267 % N/A
Total THC
(Total THC = (THCA x 0.877) + THC)
24.3 % N/A
Total CBD
(Total CBD = (CBDA x 0.877) + CBD)
ND N/A

PES.1: Pesticides, Insecticides, Fungicides and Growth Regulators by LC-MS/MS

Preparation: Sep 28, 2021

Analysis: Sep 29, 2021

Analyte Detected Pass/Fail
Bifenthrin ND Pass
Cyfluthrin ND Pass
Daminozide ND Pass
Etoxazole ND Pass
Analyte Detected Pass/Fail
Imazalil ND Pass
Myclobutanil ND Pass
Spiromesifen ND Pass
Trifloxystrob-
in
ND Pass

HME.1: Heavy Metals by ICP-MS

Preparation: Sep 28, 2021

Analysis: Sep 28, 2021

Analyte Detected Pass/Fail
Arsenic < LOQ Pass
Cadmium ND Pass
Lead ND Pass
Mercury ND Pass

* For quality assurance purposes. Not a Maine compliance certificate.

All tests were performed in accordance with the rules and regulations set forth in the Maine Adult Use Program. Laboratory sampling protocols are governed by the OMP's sampling guidance documents. All information provided by the client, including self sampling, must be accurate and adhere to the same rules and regulations. However, client provided information, including sampling, is ultimately the responsibility of the providing licensee, registered caregiver, patient or the like and failure to follow said protocols could lead to erroneous test results. Note: not all potential and/or existing hazards were analyzed.

End of Report